GPB Scientific is a pioneering biomedical company working with leading research institutes and universities to develop breakthrough technologies to get people better. GPB Scientific's Curate™ Cell Processing System applies microfluidic deterministic lateral displacement in advanced biocompatible cartridges and an easy to use robust, closed fluid path instrumentation system to consolidate multiple processing steps to reduce processing time and provide enhanced cell recovery gently and without cell damage.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/02/20 | $25,500,000 | Venture |
Amgen Business Development Vensana Capital  | undisclosed |
